23 March 2015
The Global Steering Committee is harnessing the collective capabilities and innovations of major health development institutions to combat falsified, substandard, stolen and diverted medicines and other health products.
By convening a coalition of multilateral and bilateral organizations, the Global Steering Committee, or GSC, is committed to supporting efforts that expand access to safe and effective medicines and other health products all over the world. The GSC stresses country-level partnership and capacity strengthening.
“We have an urgent responsibility to understand the scope and scale of threats to safe delivery of medicines, and to take decisive and coordinated action to prevent, detect and respond to issues that arise,” said Norbert Hauser, the GSC’s first Chairman, who is a former Inspector General of the Global Fund.
The GSC is meeting in Geneva on 26 March 2015, following an inaugural meeting in November 2014. The GSC’s initial members include the Global Fund, the U.S. President’s Malaria Initiative, USAID, WHO, World Bank, GAVI, UNDP, UNITAID, and the U.S. Food and Drug Administration.
Representatives from regulatory and law enforcement agencies, non-governmental organizations and the pharmaceutical industry, including innovators and generic manufacturers, will be invited to join the GSC to contribute to an enhanced drug quality assurance framework, supply chain integrity, and expanded public awareness. The coalition plans to meet on a quarterly basis to determine strategic direction and review recommendations from its working groups.
The Global Fund actively supports efforts to detect falsified, substandard, stolen and diverted medicines and other health products.
0 comments:
Post a Comment